
Date | Insider | Price | Amount |
---|---|---|---|
12-8-2021 Insider Buy |
Andrew Sinclair Director |
$14.00 CAGR » |
$7,000,000.00 500,000 shares |
5-13-2014 Insider Buy |
Alan G. Levin Director |
$18.38 CAGR » |
$18,380.00 1,000 shares |
2-17-2012 Insider Buy |
David B. Rosen Sr. V.P. - Rising Pharma |
$8.38 CAGR » |
$41,884.50 5,000 shares |
2-16-2012 Insider Buy |
Salvatore J. Guccione Sr. PRESIDENT AND COO |
$8.12 CAGR » |
$40,580.00 5,000 shares |
11-29-2011 Insider Buy |
Ronald Gold President & COO - Rising Pharm |
$6.52 CAGR » |
$247,760.00 38,000 shares |
Also See: Institutional Holders of ACET
Also See: SEC filings

Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 12/09/2021 | |
End date: | 06/06/2023 | |
Start price/share: | $13.74 | |
End price/share: | $5.32 | |
Dividends collected/share: | $0.00 | |
Total return: | -61.28% | |
Average Annual Total Return: | -47.15% | |
Starting investment: | $10,000.00 | |
Ending investment: | $3,872.42 | |
Years: | 1.49 |
ACET Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent ACET insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding ACET
![]() ![]() Get Dividend Alerts ![]() Get SEC Filing Alerts ![]() ![]() |
![]() ![]() |